29 March, 2023
barnaclinic+ incorporates early diagnosis programmes for prostate and breast cancer
Cancer is one of the most common diseases. The great advances in medicine in recent years have made it possible to improve the survival rate of this disease. However, it is still the leading cause of death in the world today. One of the decisive factors for a good prognosis is the stage of development of the tumour. Many cases can be cured if detected early and treated effectively. For this reason, early cancer diagnosis programmes are a very important tool. barnaclinic+ currently has a new Medical Screening unit, which offers early diagnosis programmes for colon and rectal cancer, lung cancer, skin cancer and melanoma. This offer is now being extended to include the early diagnosis of prostate cancer, the most common tumour among men, and breast cancer, the most common among women. While the programmes themselves already existed, an updated portfolio of services has been defined. In these new programmes, as in those that already existed, patients will receive care from the best specialists in these areas, who have proven experience and are international benchmarks. Likewise, the most advanced and precise technology is available, which allows the identification of tumour lesions in their earliest stages.
2 March, 2023
barnaclínc+ launches its Medical Check-up unit
An early diagnosis is usually always synonymous with a better prognosis. Both because the pathology has not developed enough to cause irreparable damage and because in earlier stages it is possible to use less aggressive treatments that lead to a better and faster recovery. Medical reviews are a very useful tool for all of this, which is why barnaclínic+ has set up a new unit specialising in medical check-up.
27 December, 2021
Liquid biopsy shows its utility in the analysis of cancer
One of the big challenges in the treatment of cancer is its heterogeneity. Tumours can present different mutations and change with time, which means that not all treatments are effective or they generate resistance. That’s why it is important to carry out follow-ups that allow us to identify changes as they are produced. However, getting the precise samples to carry out this analysis via a tissue biopsy isn’t always easy. That’s why, in the last few years, a new method has been developed which allows to analyse tumoural DNA circulating in the blood in order to carry out this follow-up and analysis of cancer in an easy and simple way. This is known as liquid biopsy.
10 February, 2021
A new molecular test detects genetic abnormalities in tumours and improves customised cancer diagnosis and treatment
At the Grupo Hospital Clínic, we have a new option for diagnosis of advanced cancer. It is a new test using Next Generation Sequencing (NGS) technology which, by analysing the tumour’s DNA and RNA, detects multiple genetic abnormalities in 52 of your genes. This new cancer diagnostic test allows your treatment to be further customised. In addition, it improves current tests for the diagnosis of lung, colon and rectal cancer and melanoma.
26 September, 2019
The best liquid biopsy test for patients with advanced cancer arrives at barnaclínic+
From this September, barnaclínic+ Medical Oncology is providing its patients with the best liquid biopsy test currently available for advanced cancer, Guardant-360. Thanks to the agreement between the Medical Oncology and Pathology departments of the Hospital Clínic de Barcelona and the company Guardant Health, the Clínic will be the first centre in Europe to routinely use one of the most advanced liquid biopsy tests on the market.